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Abstract
Objectives
Conventional microbiological procedures for the isolation of bacteria from biological fluids
consist of culture on solid media and enrichment broth. However, these methods can delay
the microbiological identification for up to 4 days. The aim of this study was to evaluate the
analytical performance of Sysmex UF500i (Sysmex, Kobe, Japan) as a screening method
for the detection of bacteria in different biological fluids in comparison with direct Gram stain-
ing and the conventional culture on solid media and enrichment broth.
Methods
A total of 479 biological fluid samples were included in the study (180 ascitic, 131 amniotic,
56 synovial, 40 cerebrospinal, 36 pleural, 24 peritoneal, 9 bile and 3 pericardial fluids). All
samples were processed by conventional culture methods and analyzed by flow cytometry.
Direct Gram staining was performed in 339 samples. The amount of growth on culture was
recorded for positive samples.
Results
Bacterial and white blood cell count by flow cytometry was significantly higher among culture
positive samples and samples with a positive direct Gram stain compared to culture nega-
tive samples. Bacterial count directly correlated with the amount of growth on culture (Krus-
kall-Wallis H χ2(3) = 11.577, p = 0.009). The best specificity (95%) for bacterial count to
predict culture positivity was achieved applying a cut-off value of 240 bacteria/μL.
Conclusions
Bacterial and white blood cell counts obtained with flow cytometry correlate with culture
results in biological fluids. Bacterial count can be used as a complementary method along
with the direct Gram stain to promptly detect positive samples and perform other diagnostic
techniques in order to accelerate the bacterial detection and identification.
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Introduction
Early detection and identification of bacteria causing infection in biological fluids such as cere-
brospinal, abdominal (ascitic, peritoneal and bile), synovial, pleural and amniotic fluids, is cru-
cial for prompt and adequate antibiotic treatment and correct management of infection [1–3].
The classical microbiological methods to isolate bacteria from biological fluids consist of cul-
ture on solid media and enrichment broth. However, the detection and identification of bacte-
ria following these methods can be delayed between 18 hours and 4 days. Direct Gram
staining provides rapid identification information but it has a low diagnostic value since it
requires a high bacterial inoculum to be positive [4–6]. The collection of biological fluids in
blood culture bottles was introduced 20 years ago, increasing bacterial recovery and sometimes
reducing the time prior to identification [7]. Molecular techniques based on multiplex poly-
merase chain reactions (PCRs) are a good and rapid alternative for the detection of bacterial
genes in biological fluid. However, they also have the disadvantage of being expensive and
aimed at specific pathogens, thereby detecting only a limited number of microorganisms [8].
Flow cytometry could improve time to microbiological diagnosis by directly detecting bac-
teria and other cells in different biological fluids [9]. The Sysmex UF500i (Sysmex, Kobe,
Japan) is a fluorescence flow cytometer intended for urinalysis. It is able to classify and quan-
tify urine cells, including red blood cells (RBC), white blood cells (WBC) and epithelial cells
(EC). This instrument has two chambers:one chamber is intended for the detection of all other
particles, where the nucleic-acid containing cells are stained with polymethine dye; the other
chamber is intended for the detection of bacteria where only nucleic acids in bacteria are
stained. After staining, the samples are transported to a flow cell where they are analyzed by a
red semiconductor laser. Particle characterization is based on forward-scatter light, side-scat-
ter light and fluorescence. Currently, flow cytometry has been used in clinical practice to detect
culture-negative urine samples based on bacterial and WBC counts [10,11]. However, it has
also been increasingly used as a screening method to rapidly identify positive urine samples
with high bacterial concentration to perform direct identification and antimicrobial suscepti-
bility testing [12–14].
The aim of this study was to evaluate the analytical performance of Sysmex UF-500i as a
screening method for the detection of bacteria in different biological fluids in comparison with
direct Gram staining and the conventional culture on solid media and enrichment broth.
Materials and methods
Sample inclusion
Consecutive biological fluid samples received to the Clinical Microbiology Department of a
700-bed university hospital, during working days in the morning period (8 a.m– 5 p.m)
between June 2014 and November 2016 were included in the study. The samples were col-
lected in sterile tubes with no chemical preservatives and processed immediately after arrival.
Samples were processed by the routine microbiological methods and subsequently analyzed
by the Sysmex UF-500i (Sysmex, Kobe, Japan). The specimens with insufficient volume (less
than 1 mL) or presenting excess viscosity to be processed by flow cytometry were excluded
(data not recorded).
Routine microbiological procedures
Gram stain screening was performed in samples classified as urgent by the attending clinician.
Biological fluids were seeded manually on blood agar (Oxoid, Madrid, Spain), chocolate agar
(Becton Dickinson, Heidelberg, Germany), MacConkey agar (Becton Dickinson) and/or
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Schaedler agar (Becton Dickinson), and thioglycollate broth (Becton Dickinson) according to
usual protocols [15]. The positive samples were classified according to the bacterial growth
observed on the plates: growth only in the thioglycollate broth subcultures, <10 grown colo-
nies, 10–100 grown colonies and >100 grown colonies on the first seeded plates. The final bac-
terial identification was achieved using MALDI-TOF MS (matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry) (Bruker, Bremen, Germany). Detection of Myco-
plasma hominis and Ureaplasma spp., in amniotic fluids only, was performed using the Myco-
plasma IST2 (Biome´rieux, Marcy l’E´toile, France).
Flow cytometry
All samples were analyzed by flow cytometry using the UF-500i and following manufacturer’s
recommendations immediately after culture inoculation. Samples were analyzed manually;
flow cytometry required 1 mL of each sample. In this study, only bacterial, and WBC counts
provided by the UF-500i were used for sample interpretation. A high and a low positive con-
trol were processed daily as recommended by the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 22.0 (Armonk, New York). Clini-
cal and microbiological data were obtained from medical records in a fully anonymized and
de-identified manner and entered in a password-protected database. Only the authors had
access to identifying information. The different parameters measured by flow cytometry were
defined as dependent variables using the culture and Gram staining results as independent var-
iables. The distribution of independent variables across groups were compared using the
Mann-Whitney U test for the comparison of two independent variables, and the Kruskall-Wal-
lis H test for the comparison of more than two independent variables. The differences were
considered statistically significant with a p-value <0.05.
The receiver operating characteristic (ROC) curves were used to compare the UF-500i bac-
terial and WBC counts to the culture results obtained by routine procedure. The cut-off values
were chosen based on best balance between sensitivity and specificity, giving priority to speci-
ficity in order to detect culture positive samples with IBM SPSS Statistics 22.0 (Armonk, New
York).
Ethical statement
The study was reviewed by the Ethical Research Committee at Hospital Clı´nic of Barcelona,
Spain, waiving the requirements for approval and consent. The study was carried out without
additional intervention of patients, all samples were processed following the routine proce-
dures, and patient’s data were anonymized before the analysis. Informed consent was not
required.
Results
Gram staining and culture results
A total of 493 biological fluids were analyzed by flow cytometry but 14 samples positive only
for Candida spp. were excluded. Finally, 479 biological fluids originating from 408 patients
were included in the study. The mean age was 57 years (interquartile range (IQR): 38–71) and
58.9% were female. The samples included as well as the number of positive and negative cul-
tures and the final bacterial identification for each type of biological fluid are shown in
Table 1. In 83 (17.3%) samples bacterial growth was detected by culture.
Flow cytometry to detect bacteria in biological fluids
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Fig 1 summarizes the results obtained from the biological fluids included in the study
according to culture, Gram staining, level of growth on cultured plates and flow cytometry
results. Gram stain was requested in 339 (70.8%) samples presenting a sensitivity of 48.84%
and a specificity of 98.97% for the total of samples in our study.
Flow cytometry counts according to culture and Gram stain results
Table 2 shows the median and IQR values of WBC/μL and bacteria/μL count estimated by
flow cytometry of the samples included in the study according to culture positivity, Gram stain
and amount of growth on the plates. Fig 2 shows the distribution of bacterial count by flow
cytometry according to the amount of growth on cultured plates.
Receiver operating characteristic (ROC) curves
The ROC curves of bacteria/μL and culture positivity yielded an area under the curve (AUC)
of 0.769 (95%CI 0.703–0.834) for all samples (Fig 3) and an AUC of 0.879, 0.784, 0.785, 0.737
and 0.571 for amniotic, synovial, cerebrospinal, ascites and peritoneal fluids, respectively (S1
Fig). The ROC curves for pericardial, bile and pleural fluids were not calculated due to the low
number of pericardial and bile fluids included and because of the low number of positive sam-
ples among pleural fluids (Table 1).
Table 1. Microbiological culture results and bacterial identifications obtained from the biological fluids included in the study.
Culture (N) Ascitic
fluid
(180)
Amniotic
fluid
(131)
Synovial
fluid
(56)
Cerebrospinal
fluid
(40)
Peritoneal
fluid
(24)
Bile
(9)
Pleural
fluid
(36)
Pericardial
fluid
(3)
Negative, n (%) 162 (90) 107 (81,7) 45 (80,4) 27 (67,5) 14 (58,3) 3 (33,3) 35 (97,2) 3 (100)
Positive, n (%) 18 (10) 24 (18,3) 11 (19,6) 13 (32,5) 10 (41,7) 6 (66,7) 1 (2,8) 0 (0)
Polymicrobial, n (%) 4c (22,2) 6d (25) 0 (0) 3e (23,1) 4f (40) 5g (83,3) 0 (0) 0
Monomicrobial culture, n (%) 14 (77,8) 18 (75) 11 (100) 10 (76,9) 6 (60) 1 (16,7) 1 (100) 0
Staphylococcus epidermidis (10) 1 2 2 4 1 - - -
Staphylococcus aureus (8) 1 1 5 - 1 - - -
Other CNSa (6) 3 - 1 2 0 - - -
Non-fermenter GNBb (5) 1 1 1 - 2 - - -
Enterobacteriaceae (10) 2 3 1 2 1 1
Anaerobe GNB b (4) - 4 - - - - - -
Enterococcus spp. (7) 5 - - 2 - - - -
Streptococcus viridans group (4) 1 1 - - 1 - 1 -
Streptococcus agalactiae (3) - 2 1 - - - - -
Peptostreptococcus spp.(1) - 1 - - - - - -
Gardnerella vaginalis (1) - 1 - - - - - -
Mycoplasma hominis/
Ureaplasma spp. (2)
- 2 - - - - - -
a CNS: Coagulase negative staphylococci
b GNB: Gram negative bacilli
c Pseudomonas aeruginosa + Bacteroides vulgatus, P. aeruginosa + Enterococcus faecium, Enterococcus faecalis + CNS, Streptococcus anginosus +E.faecalis
d Mycoplasma hominis + Ureaplasma urealyticum (2), Streptococcus agalactiae + Candida albicans, S. agalactiae + Prevotella bivia, Fusobacterium spp. + C. albicans,
Peptoniphilus harei + P. bivia
e P. aeruginosa + Staphylococcus aureus, Clostridium perfingens+ Clostridium baratii, Enterobacter aerogenes + Klebsiella oxytoca + E. faecalis;
f Mixed flora not identified (2), E. faecium + K. oxytoca, Citrobacter freundii + Klebsiella pneumoniae
g P. aeruginosa + K. pneumoniae, Escherichia coli + Morganella morganii + K. oxytoca, Enterobacter aerogenes + P. aeruginosa, E. coli + Candida glabrata, E, faecium + P.
aeruginosa.
https://doi.org/10.1371/journal.pone.0220307.t001
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The ROC curve of WBC/μL and culture positivity yielded an AUC of 0.59 (95% CI 0.513–
0.671) for the total of samples (Fig 3). The WBC counts were not used in further analysis since
the data provided by this parameter alone or in combination with bacterial counts was not
strong to predict culture positivity.
The optimal cut-off point from ROC analysis of bacterial count to predict culture positivity
was established at 240 bacteria/μL, with a subsequent sensitivity of 48.2%, specificity of 94.7%,
negative predictive value (NPV) of 89.7% and positive predictive value (PPV) of 65.6% for the
total of biological fluids. Applying this cut-off value a 93% correlation between Gram stain and
flow cytometry was obtained (Fig 1).
Amniotic fluids were analyzed separately due to the good performance of bacterial counts
to predict culture positivity in this type of sample; here, the optimal cut-off point was estab-
lished at 150 bacteria/μL with a sensitivity of 83.3%, specificity of 92.5%, NPV of 96.1% and
PPV of 71.4%.
Applying the calculated cut-off point (240 bacteria/ μL) to the total of samples, 21 samples
of 479(4,38%) with bacterial counts over the cut-off value by flow cytometry and culture
Fig 1. Gram staining, culture, level of growth on cultured plates and flow cytometry results of the biological
samples included in the study. � Thi: growth only in the thioglycollate broth subcultures,<10 grown colonies on
cultured plates, 10–100 grown colonies on cultured plates,>100 grown colonies on cultured plates.
https://doi.org/10.1371/journal.pone.0220307.g001
Table 2. Median and interquartile ranges of flow cytometry parameters according to culture positivity direct gram staining and level of growth on cultured plates.
Bacteria/μL WBC/μL
Median IQR Median IQR
Culture negative (n = 396) 17.8 8–45.6 p<0.0001a 89.9 31.1–305.4 p = 0.009a
Culture positive (n = 83) 205.3 20.9–1178.4 291.5 27.2–3345.5
Direct negative Gram staining (n = 312) 20.05 9.0–49 p<0.0001a 81.4 30.3–284.8 p = 0.008a
Direct positive Gram staining (n = 27) 1178.4 80–6792.8 384.6 37.1–3282.4
Growth only in thioglycollate broth
(n = 6)
17.5 10.3–3049.2 p = 0.009b 41.2 11.8–718.5 p = 0.31
Growth <10 colonies /plate (n = 25) 67.7 14.5–336.6 215.4 31.4–1515.5
Growth 10–100 colonies /plate (n = 14) 261.4 56.9–586.9 2609.9 49.9–10562.9
Growth >100 colonies /plate (n = 38) 671.9 37.0–8557.6 364.0 20.9–2404.9
a Mann-Whitney
b Kruskall-Wallis H χ2(3) = 11.577
https://doi.org/10.1371/journal.pone.0220307.t002
Flow cytometry to detect bacteria in biological fluids
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Fig 2. Distribution of bacterial count by flow cytometry according to the level of growth on cultured plates. IQR:
interquartile range Thioglycollate: growth only in the thioglycollate broth subcultures,<10 grown colonies on cultured
plates, 10–100 grown colonies on cultured plates,>100 grown colonies on cultured plates.
https://doi.org/10.1371/journal.pone.0220307.g002
Fig 3. ROC curve for bacterial count (BACT) and leukocyte count (WBC) by flow cytometry versus culture
positivity for 479 biological fluid samples with 83 samples positive by culture. AUC: Area under the curve.
https://doi.org/10.1371/journal.pone.0220307.g003
Flow cytometry to detect bacteria in biological fluids
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negative were obtained from 20 patients (6 ascitic, 6 amniotic, 5 articular, 2 pericardial and 2
peritoneal fluids).
In 14 of these 20 patients (70%) a final diagnosis of infection was established based on clini-
cal symptoms. Among these 14 patients, the infectious etiology was confirmed in 8 patients by
other samples (such as blood cultures or other biological fluids) positive for bacterial culture in
the same episode (two samples with positive direct Gram staining). The remaining 6 patients
did not have any positive microbiological sample.
Twelve patients out of 20 (60%) with samples showing high bacterial counts by flow cytom-
etry and culture negative results were under antibiotic treatment when the biological fluid was
obtained.
Discussion
Rapid bacterial detection in biological fluids is crucial for targeted antibiotic administration
and management of the infection. Classical microbiological methods consist of culture on
solid media and enrichment broth or collection of the samples in blood culture bottles. These
methods can delay the microbiological results for up to 4 days. Direct detection and quantifica-
tion of bacteria and WBC by flow cytometry allows rapid detection of presumed positive sam-
ples. We evaluated the flow cytometer UF-500i (Sysmex) as a screening method for the rapid
detection of bacteria in different biological fluid samples and compared it with the growth on
solid media and enrichment broth and with the results obtained by direct Gram stain. There
was consensus between bacterial count by flow cytometer and culture results. The samples
with a positive culture showed statistically higher bacterial counts than samples with negative
culture, and the bacterial count directly correlated with the growth amount on the seeded
plates (Table 2, Fig 2). Regarding Gram staining, samples with a positive direct Gram stain
showed statistically higher bacterial counts than samples with negative Gram stain. Addition-
ally, WBC count in culture positive samples was statistically higher compared to culture nega-
tive samples and in samples with positive direct Gram stain compared to samples with
negative Gram stain, nevertheless WBC count do not improve the detection of positive sam-
ples comparing with bacterial count alone.
Direct detection and quantification of bacteria in sterile biological fluids by flow cytometry
could accelerate the microbiological etiology detection. The main limitation is the low volume
provided in many cases (less than 1 mL), not sufficient to perform flow cytometry analysis,
and the excessive viscosity due to high human cell concentrations in some samples, which
could impair the count of particles. Flow cytometry has been demonstrated to correctly classify
and quantify WBC in cerebrospinal and peritoneal fluids [16–20]. Our results are in agreement
with previous studies which have mainly evaluated bacterial counts by flow cytometry in cere-
brospinal fluids, showing a good correlation with bacterial culture. However, these studies
included a low number of bacterial meningitis cases (a maximum of 7% culture positive sam-
ples) [16,18,20]. Saito et. al. evaluated an experimental bacterial counter based on flow cytome-
try on different biological fluids. Applying a cut-off between 40–100 bacteria/μL according to
the type of sample a 84.4% sensitivity and 86.0% specificity was obtained to predict culture
positivity [21].
Samples with bacterial counts above the cut-off values show a high probability of being cul-
ture positive (65.6% PPV), thus warranting further diagnostic methods to accelerate microbio-
logical identification. Many protocols based on screening by flow cytometry have been
proposed for urine samples. Direct identification by mass-spectrometry, [12–14] direct antimi-
crobial susceptibility testing [13] and direct detection of extended spectrum β-lactamase and
carbapenemase production [22] have been successfully performed for urine samples with high
Flow cytometry to detect bacteria in biological fluids
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microbial concentration. Other studies proposed a short incubation step before direct identifi-
cation for samples with lower bacterial concentration [23].
Although samples with low bacterial counts show low probability of being culture positive
(89.7% NPV) microbiological culture should not be eliminated for biological fluids, as it has
been suggested for urine cultures [10,11,24–29], due to the severity of these infections and the
presence of false negatives in the screening performance.
Flow cytometry can barely replace Gram staining as a screening method in biological fluids.
However, it can provide additional information regarding bacterial counts which along with
the Gram staining results can be used for the decision criteria on whether to apply or not rapid
identification or antibiotic susceptibility techniques. Moreover, in laboratories where Gram
stain is not always performed due to high amount of samples, flow cytometry could be used as
a screening method. Compared to Gram staining, flow cytometry has the advantages of being
faster and easier to perform and a good correlation between both techniques (93%) with the
same sensitivity (48–49%) was shown.
Although an initial inversion is required for the incorporation of flow cytometry to the
microbiology laboratory, its use in biological fluids would provide a new application, especially
for laboratories already performing urine screening with flow cytometry.
The main limitations of our study were that some biological fluids (data not recorded) were
not adequate for flow cytometry analysis: some cerebrospinal fluids were excluded since the
volume provided was under 1 mL; other samples like some synovial and abdominal fluids
could not be analyzed by flow cytometry due to excess of viscosity.
We analyzed the samples together without taking into account particular characteristics of
the different types of fluid which could influence in the performance of the assay. Finally, fur-
ther diagnostic techniques such as direct 16s rRNA gene sequencing were not performed on
culture negative samples with high bacterial counts by flow cytometry. However, in 14/20
patients with samples presenting high bacterial counts by flow cytometry and culture negative
results, a final diagnosis of infection was established, and 12/20 patients were under antibiotic
treatment when the sample was obtained. These results suggest that bacterial counts detected
by flow cytometry may have corresponded to viable but nonculturable bacterial cells [30].
To our knowledge, this is the firsts study to evaluate the UF-500i performance for bacterial
detection in a variety of biological samples.
In conclusion, the bacterial and WBC load according to the UF-500i correlate with culture
results in biological fluids and can be used as a complementary method along with the direct
Gram stain to promptly detect positive samples and perform other diagnostic techniques in
order to accelerate the bacterial detection and identification.
Supporting information
S1 Fig. ROC curves for bacterial counts by flow cytometry versus culture positivity for each
analyzed biological fluid. AUC: Area under the curve.
(TIF)
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